Getting the right medicine, to the right patient, at the right time, has long been the central mantra of those involved in the generic and biosimilar industries. The UK has been regarded with envy by other countries due to the success of its competitive off-patent medicines market, which has consistently delivered huge savings to the NHS while also guaranteeing security of supply. Four out of every five prescription medicines are met by generics or biosimilars and they are fundamental to the safe running of the NHS as well as the health and well-being of its patients.
Researchers at the University of Liège, Belgium, have developed a process for producing bio-based polyurethane (PU) foams, which are recyclable and free of isocyanate, at room temperature.
The use of wearable electronics for healthcare is driving interest in green energy sources to power and make them maintenance-free. Now, researchers in Australia say they have developed wearable devices that can generate enough energy from sweat to power a smartwatch or a Fitbit. What’s more, the energy generated can be stored.
Researchers are studying a nasal spray that safely treats recurrent episodes of a condition that causes rapid abnormal heart rhythms. In a study published in the Journal of the American College of Cardiology, they reported that the drug etripamil quickly relieved patients’ symptoms when used at home, and without the need for medical supervision.
A joint report from the European Investment Bank (EIB) and the European Patent Office (EPO) indicates that low-carbon technologies, clean mobility, and alternatives to plastics are the leading fields in cleantech innovation in Europe.
Psychedelic or mind-bending compounds are most usually associated with mushrooms. But it’s likely that humans produce them too, while recent research suggests they could even be responsible for near death and ‘out of body’ experiences, reports Jasmin Fox-Skelly
Read the latest applied chemistry highlights for May 2024 by Nigel P Freestone | University of Northampton, UK.
Long Covid is a complex multifactorial disease, but recent research is shedding light on the underlying mechanisms. The findings have implications for the way the disease is being treated, Maria Burke reports
Developing a comprehensive strategy for protecting your innovation is essential to protecting your company’s assets. Many innovations protected by applying for a patent could also be protected as trade secrets. A granted patent provides rights to exclude others from using the patented invention for a period of up to 20 years from filing. By contrast, there is no fixed term of protection for trade secrets. A trade secret may retain the exclusive innovation of a company for as long as it remains secret.
New drugs hitting the market and in the pipeline for obesity are reshaping how we treat the condition. With nearly two-thirds of Europeans overweight or obese, they can’t come soon enough, Katrina Megget reports